WallStSmart
CAPR

Capricor Therapeutics Inc

NASDAQ: CAPR · HEALTHCARE · BIOTECHNOLOGY

$33.58
+3.45% today

Updated 2026-04-30

Market cap
$2.04B
P/E ratio
P/S ratio
124.43x
EPS (TTM)
$-2.26
Dividend yield
52W range
$4 – $40
Volume
1.3M

Capricor Therapeutics Inc (CAPR) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-55597.00$-5.37M$-10.64M$-5.80M$-4.32M$-4.65M$-2.19M$-6.14M$958562.00$-10.82M$-15.80M$-14.23M$-13.86M$-6.82M$-10.05M$-16.81M$4.92M$-25.60M$-40.00M$-69.81B
Capital expenditures$0.00$288900.00$92630.00$36726.00$2205.00$1987.00$13428.00$109345.00$186431.00$151227.00$193739.00$32185.00$316486.00$547601.00$547601.00$1.20M$3.36M$2.05M$1.54M$2.90B
Depreciation
Stock-based comp$3.08M$3.04M$2.25M$1.12M$806327.00$312690.00$263593.00$496939.00$1.57M$1.96M$1.71M$1.73M$700984.00$1.95M$2.97M$4.46M$7.39M$9.77M$16.97B
Free cash flow$-55597.00$-5.66M$-10.73M$-5.83M$-4.32M$-4.65M$-2.20M$-6.25M$772131.00$-10.97M$-16.00M$-14.26M$-14.18M$-7.37M$-10.60M$-18.01M$1.56M$-27.64M$-41.53M$-72.72B
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$-2.34M$-992474.00$1.56M$6.31M$-2.47M$-2.36M$2.33M$-2.34M$-645769.00$28.77M$2.22M$-25.28M